Table 1.
Genes inhibited | Top1 cKOveh value* | Top1 cKOtopot value | Fold inhibition |
| |||
Cadm2 | 29.7 | 6.37 | 4.66 |
Nkain2 | 10.23 | 2.32 | 4.41 |
Syt1 | 180.8 | 70.4 | 2.57 |
Nrg3 | 9.91 | 2.8 | 3.54 |
Nbea | 15.3 | 5.77 | 2.65 |
Kcnip4 | 11.68 | 3.18 | 3.67 |
Luzp2 | 23.6 | 7.5 | 3.15 |
Opcml | 36.4 | 14.43 | 2.52 |
Negr1 | 60.1 | 26.2 | 2.3 |
Lphn3 | 9.41 | 3.29 | 2.86 |
Vps13b | 2.64 | 0.85 | 3.11 |
Pcdh11x | 5.13 | 1.67 | 3.07 |
Tenm1 | 3.51 | 1.03 | 3.41 |
Grm7 | 8.63 | 2.9 | 2.98 |
Grm5 | 18.6 | 7.24 | 2.57 |
Nrxn3 | 10.75 | 4.58 | 2.35 |
Galntl6 | 2.17 | 0.42 | 5.17 |
Robo2 | 8.32 | 3.24 | 2.57 |
Dgkb | 12.49 | 4.98 | 2.51 |
Spock3 | 27.9 | 11.81 | 2.36 |
Erc2 | 23.7 | 11.18 | 2.12 |
Pcdh9 | 13.2 | 5.23 | 2.52 |
Mctp1 | 9.73 | 3.9 | 2.5 |
Dpp10 | 12.8 | 5.41 | 2.37 |
March1 | 8.34 | 3.44 | 2.42 |
Npas3 | 2.43 | 0.51 | 4.77 |
Htr2c | 11.5 | 4.79 | 2.4 |
Gria4 | 17 | 7.21 | 2.36 |
Reln | 10.07 | 2.46 | 4.09 |
Gucy1a2 | 9.35 | 4.17 | 2.24 |
Akt3 | 48.7 | 24.6 | 1.98 |
Ppfia2 | 11.98 | 4.93 | 2.43 |
Slc4a4 | 18.8 | 4.73 | 3.98 |
Gphn | 13.4 | 5.7 | 2.35 |
Ptprd | 10.4 | 4.76 | 2.19 |
Adarb2 | 1.84 | 0.39 | 4.72 |
Ctnna2 | 25 | 11.7 | 2.14 |
Epha5 | 20.7 | 10.5 | 1.97 |
| |||
Genes induced | Top1 cKOveh value | Top1 cKOtopot value | Folds induction |
| |||
Cdkn1a | 92.8 | 210.3 | 2.27 |
Phlda3 | 48.1 | 99.2 | 2.06 |
Slc5a3 | 7.16 | 15.8 | 2.21 |
Nes | 8.7 | 20.9 | 2.4 |
Top1, topoisomerase I;
cKO, conditional knockout; veh, vehicle treated; topot, topotecan treated.